For a client on anticoagulation therapy, which outcome would indicate a need for further evaluation?

Frequent bruising in a client on anticoagulation therapy could indicate an increased risk of bleeding complications. Anticoagulants are designed to prevent blood clots, but they can also heighten the likelihood of minor bleeding events, such as bruises, due to their effect on the coagulation process. When a client experiences frequent bruising, it may signal that their anticoagulation therapy is either too effective, meaning the blood is not clotting as it should, or there may be underlying issues with platelet function or blood vessel integrity. This warrants further evaluation by a healthcare provider to assess the appropriateness of the current anticoagulant dosage, to explore potential interactions with other medications, or to investigate any underlying conditions that may be affecting the client’s coagulation status.

Other outcomes, such as stable blood pressure, a normal range of INR, and no signs of bleeding, suggest that the anticoagulation therapy is being managed effectively. A stable blood pressure indicates there are no acute bleeding events leading to shock, a normal INR shows that the blood's clotting ability is within the desired therapeutic range, and the absence of any signs of bleeding demonstrates that the therapy is currently not causing any adverse effects. However, the presence of frequent bruising stands